Z-0258-2025 Class III Ongoing
FDA device recall Z-0258-2025 was initiated by DRG International, Inc. on Sep 13, 2024 and is designated Class III. Reason for recall: The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the… The recall status is ongoing. Affected quantity: 504 units.
Recall details
- Product Type
- Devices
- Report Date
- Nov 6, 2024
- Initiation Date
- Sep 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 504 units
Product description
17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292
Reason for recall
The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.
Distribution pattern
AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam
Code information
Lot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0258-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026